Effects of Semaglutide in HIV-Associated Lipohypertrophy (NCT04019197)
Effects of GLP-l Receptor Agonists on Cardiometabolic Alterations in HIV-associated Lipohypertrophy
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a randomized, double-blinded, placebo-controlled trial designed to assess the effect of the GLP-1 receptor agonist, semaglutide, on visceral and ectopic fat, insulin resistance, inflammation markers, and the downstream effect of cardiovascular risk in people with HIV. The primary endpoints will be visceral and ectopic fat changes over the study period. The secondary endpoints will include changes in markers of inflammation, immune activation, gut integrity, and cardiovascular disease risk assessment.
Who can join: Review the eligibility criteria below.
Location: Case Western Reserve University โ Cleveland, Ohio
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Case Western Reserve University โ Cleveland, Ohio
- Medical University of South Carolina โ Charleston, South Carolina
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV/AIDS
- Optimizing Tobacco Use Treatment for PLWHA โ Chicago, Illinois
- Intervention for Virologic Suppression in Youth โ San Francisco, California
- ResIlience-based Stigma REdUction Program ("Rise-up") โ Columbia, South Carolina
- Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana โ Philadelphia, Pennsylvania
- The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls โ Paterson, New Jersey
Explore by condition: All HIV/AIDS clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.